178 related articles for article (PubMed ID: 16574200)
1. Factor XIII in severe sepsis and septic shock.
Zeerleder S; Schroeder V; Lämmle B; Wuillemin WA; Hack CE; Kohler HP
Thromb Res; 2007; 119(3):311-8. PubMed ID: 16574200
[TBL] [Abstract][Full Text] [Related]
2. TAFI and PAI-1 levels in human sepsis.
Zeerleder S; Schroeder V; Hack CE; Kohler HP; Wuillemin WA
Thromb Res; 2006; 118(2):205-12. PubMed ID: 16009400
[TBL] [Abstract][Full Text] [Related]
3. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
4. Elevated nucleosome levels in systemic inflammation and sepsis.
Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
[TBL] [Abstract][Full Text] [Related]
5. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor in severe sepsis and septic shock.
Karlsson S; Pettilä V; Tenhunen J; Lund V; Hovilehto S; Ruokonen E;
Anesth Analg; 2008 Jun; 106(6):1820-6. PubMed ID: 18499616
[TBL] [Abstract][Full Text] [Related]
7. Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction.
Zeerleder S; Hack CE; Caliezi C; van Mierlo G; Eerenberg-Belmer A; Wolbink A; Wuillenmin WA
Clin Immunol; 2005 Aug; 116(2):158-65. PubMed ID: 15993363
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
9. [Early changes in function of hypothalamic-pituitary-target gland axis in patients with severe sepsis and septic shock].
Cui N; Liu DW; Wang H; Zeng ZP; Long Y; Chai WZ; Liu HZ; Wang XT
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):332-5. PubMed ID: 17577436
[TBL] [Abstract][Full Text] [Related]
10. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
Siebenlist KR; Meh DA; Mosesson MW
Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
[TBL] [Abstract][Full Text] [Related]
11. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability.
Waeschle RM; Moerer O; Hilgers R; Herrmann P; Neumann P; Quintel M
Crit Care; 2008; 12(5):R129. PubMed ID: 18939991
[TBL] [Abstract][Full Text] [Related]
12. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.
Mikkelsen ME; Miltiades AN; Gaieski DF; Goyal M; Fuchs BD; Shah CV; Bellamy SL; Christie JD
Crit Care Med; 2009 May; 37(5):1670-7. PubMed ID: 19325467
[TBL] [Abstract][Full Text] [Related]
13. [Fibrinolysis system in patients with sepsis in state of myelotoxic agranulocytosis].
Galstian GM; Krechetova AV; Vasil'ev SA; Orel EB; Pustovoĭt LA; Egorova EO; Saridi EIu; Gemdzhian EG; Gorodetskiĭ VM
Anesteziol Reanimatol; 2012; (2):41-8. PubMed ID: 22834287
[TBL] [Abstract][Full Text] [Related]
14. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
[TBL] [Abstract][Full Text] [Related]
15. Protein C concentrations correlate with organ dysfunction and predict outcome independent of the presence of sepsis.
Brunkhorst F; Sakr Y; Hagel S; Reinhart K
Anesthesiology; 2007 Jul; 107(1):15-23. PubMed ID: 17585211
[TBL] [Abstract][Full Text] [Related]
16. Substrates of Factor XIII-A: roles in thrombosis and wound healing.
Richardson VR; Cordell P; Standeven KF; Carter AM
Clin Sci (Lond); 2013 Feb; 124(3):123-37. PubMed ID: 23075332
[TBL] [Abstract][Full Text] [Related]
17. Factor XIII and venous thromboembolism.
Bereczky Z; Muszbek L
Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
[TBL] [Abstract][Full Text] [Related]
19. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.
Sundén-Cullberg J; Nyström T; Lee ML; Mullins GE; Tokics L; Andersson J; Norrby-Teglund A; Treutiger CJ
Crit Care Med; 2007 Jun; 35(6):1536-42. PubMed ID: 17452927
[TBL] [Abstract][Full Text] [Related]
20. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
